Selecta Biosciences to Participate at the William Blair Biotech Focus Conference 2021

Rhea-AI Summary

Selecta Biosciences, Inc. (NASDAQ: SELB) announced participation in the William Blair Biotech Focus Conference 2021, taking place virtually on July 14-15. CEO Carsten Brunn, Ph.D., will hold one-on-one investor meetings, while CSO Takashi Kei Kishimoto, Ph.D., will join a panel discussion titled Delivery and Durability of Genetic Medicines on July 15 at 10:00 a.m. ET. Selecta focuses on developing tolerogenic therapies through its ImmTOR™ platform, aimed at reducing unwanted immune responses and enhancing the effectiveness of biologic treatments.

WATERTOWN, Mass., July 08, 2021 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced that Selecta’s Chief Executive Officer, Carsten Brunn, Ph.D., will participate in one-on-one investor meetings and Chief Science Officer, Takashi Kei Kishimoto, Ph.D., will participate in a panel discussion at the William Blair Biotech Focus Conference 2021 to be held virtually, July 14-15.

Details on the panel can be found below.

Title: Delivery and Durability of Genetic Medicines
Date & Time: Thursday, July 15 at 10:00 a.m. ET

About Selecta Biosciences, Inc.
Selecta Biosciences Inc. (NASDAQ: SELB) is a clinical stage biotechnology company leveraging its ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses. With a proven ability to induce tolerance to highly immunogenic proteins, ImmTOR has the potential to amplify the efficacy of biologic therapies, including redosing of life-saving gene therapies, as well as restore the body’s natural self-tolerance in autoimmune diseases. Selecta has several proprietary and partnered programs in its pipeline focused on enzyme therapies, gene therapies, and autoimmune diseases. Selecta Biosciences is headquartered in the Greater Boston area. For more information, please visit www.selectabio.com.

For Investors:
Bruce Mackle
LifeSci Advisors, LLC
+1-929-469-3859
bmackle@lifesciadvisors.com

For Media: 
Brittany Leigh, Ph.D.
LifeSci Communications, LLC
+1-646-751-4366
bleigh@lifescicomms.com 

FAQ

What is the date of the William Blair Biotech Focus Conference 2021 for Selecta Biosciences?

The William Blair Biotech Focus Conference 2021 will take place virtually on July 14-15, 2021.

Who from Selecta Biosciences will participate in the conference?

Carsten Brunn, CEO, will conduct one-on-one investor meetings, and Takashi Kei Kishimoto, CSO, will participate in a panel discussion.

What is the topic of the panel discussion featuring Selecta Biosciences?

The panel discussion will focus on Delivery and Durability of Genetic Medicines.

What is Selecta Biosciences' stock symbol?

Selecta Biosciences trades under the stock symbol SELB on NASDAQ.

What is Selecta Biosciences' ImmTOR™ platform?

Selecta's ImmTOR™ platform develops tolerogenic therapies designed to mitigate unwanted immune responses and improve biologic therapies.